TROMBETTA, Maddalena
 Distribuzione geografica
Continente #
NA - Nord America 6.453
EU - Europa 5.939
AS - Asia 4.079
SA - Sud America 587
Continente sconosciuto - Info sul continente non disponibili 256
AF - Africa 128
OC - Oceania 12
Totale 17.454
Nazione #
US - Stati Uniti d'America 6.287
RU - Federazione Russa 2.227
SG - Singapore 1.522
GB - Regno Unito 1.520
CN - Cina 1.089
IT - Italia 600
BR - Brasile 464
VN - Vietnam 410
HK - Hong Kong 307
DE - Germania 299
SE - Svezia 292
FR - Francia 253
FI - Finlandia 240
IE - Irlanda 203
BD - Bangladesh 186
KR - Corea 165
CA - Canada 90
IN - India 87
JP - Giappone 59
UA - Ucraina 56
NL - Olanda 52
MX - Messico 51
ID - Indonesia 45
AR - Argentina 44
PK - Pakistan 44
PL - Polonia 40
TR - Turchia 35
ZA - Sudafrica 27
AT - Austria 24
NG - Nigeria 24
IQ - Iraq 21
EC - Ecuador 20
BE - Belgio 19
ES - Italia 19
GR - Grecia 16
CO - Colombia 14
SA - Arabia Saudita 13
UZ - Uzbekistan 13
BJ - Benin 12
EG - Egitto 12
PY - Paraguay 12
CL - Cile 11
AU - Australia 10
CZ - Repubblica Ceca 10
DZ - Algeria 10
VE - Venezuela 10
LT - Lituania 9
PH - Filippine 9
GH - Ghana 8
JO - Giordania 8
IR - Iran 7
MA - Marocco 7
RO - Romania 7
TG - Togo 7
AE - Emirati Arabi Uniti 6
AZ - Azerbaigian 6
CR - Costa Rica 6
NO - Norvegia 6
TH - Thailandia 6
BG - Bulgaria 5
CH - Svizzera 5
JM - Giamaica 5
KG - Kirghizistan 5
UY - Uruguay 5
AL - Albania 4
BO - Bolivia 4
DK - Danimarca 4
ET - Etiopia 4
HU - Ungheria 4
IL - Israele 4
KE - Kenya 4
LV - Lettonia 4
MD - Moldavia 4
MY - Malesia 4
NP - Nepal 4
RS - Serbia 4
TN - Tunisia 4
CY - Cipro 3
DO - Repubblica Dominicana 3
HN - Honduras 3
LK - Sri Lanka 3
PE - Perù 3
PT - Portogallo 3
AO - Angola 2
BY - Bielorussia 2
HR - Croazia 2
KH - Cambogia 2
KZ - Kazakistan 2
LA - Repubblica Popolare Democratica del Laos 2
LB - Libano 2
LU - Lussemburgo 2
NZ - Nuova Zelanda 2
PA - Panama 2
TW - Taiwan 2
XK - ???statistics.table.value.countryCode.XK??? 2
AM - Armenia 1
CI - Costa d'Avorio 1
CV - Capo Verde 1
DM - Dominica 1
EE - Estonia 1
Totale 17.180
Città #
Southend 1.336
Ashburn 950
Dallas 858
Moscow 812
Singapore 749
Chandler 543
San Jose 538
Jacksonville 323
Hong Kong 299
Woodbridge 236
Beijing 235
Verona 234
New York 213
Ann Arbor 208
Dublin 203
Council Bluffs 191
Houston 165
Los Angeles 141
The Dalles 140
Ho Chi Minh City 120
Helsinki 91
Wilmington 85
Hanoi 80
Lawrence 78
Princeton 78
Santa Clara 68
Jinan 67
Munich 66
Buffalo 58
Nanjing 55
Milan 52
Seoul 52
Tokyo 50
Orem 46
Shenyang 45
Boardman 42
Turku 41
São Paulo 39
Dong Ket 36
Frankfurt am Main 36
Falkenstein 35
Redondo Beach 35
Warsaw 34
London 31
Sindelfingen 29
Tianjin 29
Montreal 27
Hebei 26
Phoenix 26
Redmond 26
Bologna 25
Columbus 25
Denver 24
Jakarta 24
Zhengzhou 24
Rio de Janeiro 22
Amsterdam 21
Nanchang 21
Chennai 20
Lancaster 20
Toronto 20
Brooklyn 19
Brussels 19
Haiphong 19
Romola 19
San Francisco 19
Hangzhou 18
Abuja 17
Atlanta 17
Mianwali 17
Nuremberg 17
Stockholm 17
Boston 16
Chicago 16
Rome 16
Taiyuan 16
Vienna 16
Brasília 15
Changsha 15
Dearborn 15
Haikou 15
Kent 15
Shanghai 15
Da Nang 14
Johannesburg 14
Washington 14
Mexico City 13
Paris 13
Redwood City 13
Seattle 13
Tashkent 13
Cotonou 12
Dhaka 12
Hyderabad 12
Taizhou 12
Ankara 11
Dongguan 11
Guangzhou 11
Manchester 11
Poplar 11
Totale 10.781
Nome #
American Diabetes Association 75th Scientific Meeting - Epidemiology/Genetics Section; Poster 1563-P: Pancreatic Beta-Cell Function, Insulin Sensitivity, and Metabolic Phenotypes in Type 2 Diabetes at the Time of Diagnosis—The Verona Newly Diagnosed Type 2 Diabetes Study (VNDS) 785
Common Variants Associated to Type 2 Diabetes in the Italian Population 498
Long-Acting GLP-1 Receptor Agonist Exenatide Influence on the Autonomic Cardiac Sympatho-Vagal Balance 254
VARIABLES INFLUENCING THE OPTIMAL SAMPLING DURATION OF INTERMITTENTLY-SCANNED CONTINUOUS GLUCOSE MONITORING TO ASSESS 90 DAYS OF GLYCEMIA RISK INDEX. FINDINGS FROM A MULTICENTRIC REAL-WORLD STUDY. 249
"Presence and titer of GAD antibodies are determinants of beta cell function in patients with newly diagnosed type 2 diabetes mellitus: further insights in the metabolic phenotype of LADA patients" 248
Abstracts of 51st EASD Annual Meeting 244
A renal genetic risk score (GRS) is associated with kidney dysfunction in people with type 2 diabetes 232
A low "genetic load" of risk variants for type 2 diabetes is associated to better beta cell function in patients with newly diagnosed type 2 diabetes 231
CACNA1E variants affect beta cell function in patients with newly diagnosed type 2 diabetes. the Verona newly diagnosed type 2 diabetes study (VNDS) 3. 222
Differences in the acute effects of aerobic and resistance exercise in subjects with type 2 diabetes: results from the RAED2 randomized trial 219
Association of free-living physical activity measures with metabolic phenotypes in type 2 diabetes at the time of diagnosis. The Verona Newly Diagnosed Type 2 Diabetes Study (VNDS) 219
11-6: CONTINUOUS GLUCOSE MONITORING AND ASSESSMENT OF LONG-TERM ISLET FUNCTION IN AUTOLOGOUS ISLET TRANSPLANTATION AFTER TOTAL PANCREATECTOMY FOR PANCREATIC NEOPLASIA: PRELIMINARY DATA FROM THE VERONA COHORT 218
Relationship of Chronic Vascular Complications with Beta-Cell Dysfunction and Insulin Resistance in Newly Diagnosed Type 2 Diabetes: The Verona Newly Diagnosed Type 2 Diabetes Study (VNDS) 215
Nonalcoholic Fatty Liver Disease Is Independently Associated With an Increased Incidence of Chronic Kidney Disease in Patients With Type 1 Diabetes. 212
Association between subclinical left ventricular systolic dysfunction and glycemic control in asymptomatic type 2 diabetic patients with preserved left ventricular function 211
Diabetic foot complicated by vertebral osteomyelitis and epidural abscess 210
Increased aortic stiffness index in patients with type 1 diabetes without cardiovascular disease compared to controls 210
Confronto delle variazioni acute della glicemia indotte dall'esercizio fisico aerobico o di forza muscolare: studio mediante holter glicemico 207
PPARG2 Pro12Ala and ADAMTS9 rs4607103 as "insulin resistance loci" and "insulin secretion loci" in Italian individuals. The GENFIEV study and the Verona Newly Diagnosed Type 2 Diabetes Study (VNDS) 4. 207
A longitudinal study of glucose tolerance in cystic fibrosis: the central role of beta cell functional mass 206
Assessement of 1th and snd phase of insulin secretion during OGTT and IVGTT 203
Interleukin-6 as a potential positive modulator of human beta-cell function: an exploratory analysis-the Verona Newly Diagnosed Type 2 Diabetes Study (VNDS) 6 201
A parsimonious model of a mixed-meal test in patients with type 1 diabetes in insulin pump therapy 201
Metabolic effects of aerobic training and resistance training in type 2 diabetic subjects: a randomized controlled trial (the RAED2 study). 197
Lower levels of 25-hydroxyvitamin D3 are associated with a higher prevalence of microvascular complications in patients with type 2 diabetes. 197
Chronic complications in patients with newly diagnosed type 2 diabetes: prevalence and related metabolic and clinical features: the Verona Newly Diagnosed Type 2 Diabetes Study (VNDS) 9 197
Genetic variability of G6PC2 influences beta cell function and insulin sensitivity in patients with newly diagnosed type 2 diabetes 196
Prevalence of Cardiovascular Autonomic Neuropathy in a Cohort of Patients With Newly Diagnosed Type 2 Diabetes: The Verona Newly Diagnosed Type 2 Diabetes Study (VNDS) 194
Aerobic and resistence exercise have different short-term effect on glucose levels in type 2 diabetes subject 192
Effects of angiotensin II receptor inhibition on insulin-induced endothelial dysfunction in humans. 192
Potential role of MTNR1B locus in regulating beta cell function and glucose levels in patients with newly diagnosed type 2 diabetes 191
Variants and haplotypes of TCF7L2 are associated with beta cell function in patients with newly diagnosed type 2 diabetes. The Verona Newly Diagnosed Type 2 Diabetes Study (VNDS).1. 187
Cutaneous squamous carcinoma in a patient with diabetic foot: an unusual evolution of a frequent complication 187
Body mass index is a potential modifier of the influence on beta cell function exerted by SLC30A8 and KCNJ11 diabetes risk variants in patients with newly diagnosed type 2 diabetes 184
Differences in the acute effects of aerobic and resistance exercise in subjects with type 2 diabetes: Results from the RAED2 randomized trial - Note in: Riddell et al., Physical activity and exercise 182
Is common genetic variation at IRS1, ENPP1 and TRIB3 loci associated with cardiometabolic phenotypes in type 2 diabetes? An exploratory analysis of the Verona Newly Diagnosed Type 2 Diabetes Study (VNDS) 5 181
Influence of health locus of control and fear of hypoglycaemia on glycaemic control and treatment satisfaction in people with Type 1 diabetes on insulin pump therapy 180
Confronto degli effetti metabolici dell'esercizio aerobico e dell'esercizio di forza nel diabete tipo 2 180
Growing up with type 1 diabetes mellitus: Data from the Verona Diabetes Transition Project 180
Relation of serum gamma-glutamyltransferase to atherogenic dyslipidemia and glycemic control in type 2 diabetes. 178
Accuracy of CGM Systems During Continuous and Interval Exercise in Adults with Type 1 Diabetes 178
Effects of Semaglutide on Glycemic Control and Weight Loss in a Patient with Prader-Willi Syndrome: A Case Report 176
Beta-cell function across the spectrum of glucose tolerance in obese youth. 175
Variants in CACNA1E affect beta cell function and glucose homeostasis in newly diagnosed type 2 diabetes patients 174
In patients with newly-diagnosed type 2 diabetes beta cell function is an independent predictor of glucose control evolution over 18 months 173
Insulin sensitivity and beta-cell function: Relationships to glycemic control in newly diagnosed Type 2 diabetic patients 172
Increased prevalence of chronic kidney disease in patients with type 1 diabetes and non-alcoholic fatty liver. 171
Haplotypes of the genes (GCK and G6PC2) underlying the glucose/glucose-6-phosphate cycle are associated with pancreatic beta cell glucose sensitivity in patients with newly diagnosed type 2 diabetes from the VNDS study (VNDS 11) 170
Continuous Glucose Monitoring and Long-Term Assessment of Islet Function in Autologous Islet Transplantation after Total Pancreatectomy for Neoplasm: Preliminary Insights from a Prospective Study 169
Impaired Aortic Valve Growth in Type 1 Diabetes Mellitus 165
Contribution of β-cell dysfunction and insulin resistance to cirrhosis-associated diabetes: Role of severity of liver disease 162
Evidence of left atrial remodeling and left ventricular diastolic dysfunction in type 2 diabetes mellitus with preserved systolic function 160
A sub-analysis of the SAGE study in Italy indicates good glycemic control in type 1 diabetes 159
Left ventricular chamber dilation and filling pressure may help to categorise patients with type 2 diabetes 159
Estimated peak systolic pulmonary artery pressure in young non-complicated patients with type 1 diabetes 158
Glomerular filtration rate decline in T2DM following diagnosis. The Verona newly diagnosed diabetes study-12 158
Increased prevalence of cardiovascular disease in type 1 diabetic patients with non-alcoholic fatty liver disease. 157
Variants of GCKR affect both beta cell and kidney function in patients with newly diagnosed type 2 diabetes. The Verona Newly diagnosed type diabets study (VNDS). 2. 156
“Genetic Load” of diabetes risk alleles affects beta-cell function in patients with newly diagnosed type 2 diabetes 155
Role of monogenic diabetes genes on beta cell function in Italian patients with newly diagnosed type 2 diabetes. The Verona Newly Diagnosed Type 2 Diabetes Study (VNDS) 13 155
Defects in the dynamic control of beta cell function and in glucose effectiveness underly the initial decline in intravenous glucose tolerance of obese European children 152
Metabolic control analysis (MCA) of intravenous glucose tolerance in healthy humans. 149
61st EASD Annual Meeting of the European Association for the Study of Diabetes SO 019 It's beta cell replacement time: 402 - Continuous glucose monitoring and assessment of islet function in autologous islet transplantation after total pancreatectomy for pancreatic neoplasia: preliminary data from the Verona cohort 147
Quantitation of the roles played by the main determinants of meal glucose tolerance in patients with type 1 diabetes on insulin pump therapy 147
PPARgamma Pro12Ala and ADAMTS9 rs4607103 are determinants of insulin sensitivity in both non-diabetic and type 2 diabetic Italian subjects 145
Changes induced by metabolic surgery on the main components of glucose/insulin system in patients with diabetes and obesity 145
Impact of CFTR Modulators on Beta-Cell Function in Children and Young Adults with Cystic Fibrosis 141
Pathogenetic Mechanisms and Cardiovascular Risk: Differences between HbA1c and oral glucose tolerance test for the diagnosis of glucose tolerance. 139
Evaluating endothelial function of the common carotid artery: An in vivo human model. 137
A Randomized Crossover Trial Comparing Glucose Control During Postprandial Moderate Aerobic Activity and High-Intensity Interval Training in Adults With Type 1 Diabetes Using an Advanced Hybrid Closed-Loop System 134
Relationship between soluble CD40 ligand and gamma-glutamyltransferase concentrations in non-drinking, young type 1 diabetic individuals 134
Different Times for Different Metrics: Predicting 90 Days of Intermittently Scanned Continuous Glucose Monitoring Data in Subjects With Type 1 Diabetes on Multiple Daily Injection Therapy. Findings From a Multicentric Real-World Study 131
Crosstalk between genetic variability of adiponectin and leptin, glucose‐insulin system and subclinical atherosclerosis in patients with newly diagnosed type 2 diabetes. The Verona Newly Diagnosed Type 2 Diabetes Study 14 127
Central role of the β-cell in driving regression of diabetes after liver transplantation in cirrhotic patients 126
Metabolic control and complications in Italian people with diabetes treated with continuous subcutaneous insulin infusion 125
Continuous subcutaneous insulin infusion in Italy: third national survey. 125
Review article: type 2 diabetes and chronic liver disease in the Verona Diabetes Study 123
Type 2 Diabetes Mellitus: a Disease of the Governance of the Glucose-Insulin System. An Experimental Metabolic Control Analysis Study. 123
Echocardiographic parameters according to insulin dose in young patients affected by type 1 diabetes 122
Uric acid is a biomarker of beta cell function in patients with newly diagnosed type 2 diabetes 120
G Protein-Coupled Receptors and the Rise of Type 2 Diabetes in Children 118
Continuous intraperitoneal insulin infusion: an alternative route for insulin delivery in type 1 diabetes 118
Heritability of model-derived parameters of beta cell secretion during intravenous and oral glucose tolerance tests: a study of twins. 117
Insulin sensitivity is correlated with subcutaneous but not visceral body fat in overweight and obese prepubertal children. 116
Metabolic syndrome in subjects at high risk for type 2 diabetes: the genetic, physiopathology and evolution of type 2 diabetes (GENFIEV) study. 116
Depressive symptoms and glycaemic control in adults with type 1 diabetes: an exploratory study on the role of family functioning 116
61st EASD Annual Meeting of the European Association for the Study of Diabetes SO 077 Hi Hypo :) I would like to know you better 854 - Detecting hypoglycaemia with glycaemia risk index in adults with type 1 diabetes using continuous glucose monitoring and multiple daily injection therapy: a multicentric real-world study 115
Markers of subclinical vascular damage in young adults with type 1 diabetes mellitus: the role of central blood pressure 115
Interactions of the Osteokines, Glucose/Insulin System and Vascular Risk Networks in Patients With Newly Diagnosed Type 2 Diabetes (VNDS 15) 113
Metabolic abnormalities underlying the different prediabetic phenotypes in obese adolescents. 112
Variability of body weight, pulse pressure and glycemia strongly predict total mortality in elderly type 2 diabetic patients. The Verona Diabetes Study. 112
Methods to assess in vivo insulin sensitivity and insulin secretion 112
Loss of ZnT8 function protects against diabetes by enhanced insulin secretion 111
Insulin resistance and beta‐cell dysfunction in newly diagnosed type 2 diabetes: Expression, aggregation and predominance. Verona Newly Diagnosed Type 2 Diabetes Study 10 108
SARS-CoV-2 and COVID-19 in diabetes mellitus. Population-based study on ascertained infections, hospital admissions and mortality in an Italian region with ∼5 million inhabitants and ∼250,000 diabetic people 106
Assessing attitudes towards insulin pump therapy in adults with type 1 diabetes: Italian validation of the Insulin Pump Attitudes Questionnaire (IT-IPA questionnaire) 99
Glucose tolerance stages in Cystic Fibrosis are idenfied by a unique pattern of defects of Beta-cell function 96
Correction to: Assessing attitudes towards insulin pump therapy in adults with type 1 diabetes: Italian validation of the Insulin Pump Attitudes Questionnaire (IT‑IPA questionnaire) 89
Lower heart rate variability, an index of worse autonomic function, is associated with worse beta cell response to a glycemic load in vivo—The Maastricht Study 87
Metformin is associated with low levels of vitamin B12 with no effect on other vitamin levels. A selective action of metformin 86
Totale 17.253
Categoria #
all - tutte 55.179
article - articoli 39.524
book - libri 0
conference - conferenze 15.210
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 445
Totale 110.358


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022428 0 0 19 55 23 36 13 32 24 18 54 154
2022/20231.427 101 196 120 255 130 323 17 80 139 14 34 18
2023/20241.308 36 61 74 102 100 217 32 308 10 130 164 74
2024/20252.367 96 134 114 449 97 90 152 79 389 137 213 417
2025/20268.031 461 522 774 1.431 1.933 516 622 383 471 450 209 259
2026/2027333 130 198 5 0 0 0 0 0 0 0 0 0
Totale 17.454